+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Genome Editing Market, By Technique (CRISPR, TALENs, Zinc Finger Nucleases, Others), By Application (Cell Line Engineering, Animal Genetic Engineering, Others), By Delivery Method, By End User, By Region, Competition Forecast & Opportunities, 2026

  • ID: 5022673
  • Report
  • August 2021
  • Region: Global
  • 110 Pages
  • TechSci Research
UP TO OFF
until Dec 31st 2021
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The Global Genome Editing Market is Expected to Reach USD 8711.24 Million by 2026, Growing at Double-Digit CAGR of 12.73% Over the Forecast Period.

FEATURED COMPANIES

  • Arcturus Therapeutics Inc
  • Beam therapeutics Inc.
  • CRISPR Therapeutics AG
  • Genscript Corp.
  • Inscripta Inc.
  • Merck & Co Inc.
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The Global Genome Editing Market is expected to reach USD8711.24 million by 2026, growing at double-digit CAGR of 12.73% over the forecast period. Growing research & development activities for the treatment of various chronic diseases and increasing preference for personalized medicine are fueling the market growth of genome editing until 2026.

Genome editing is a way of making specific changes to the DNA of a cell or organism. It could be used to edit the genome of any organism. It uses a type of enzyme called an ‘engineered nuclease’ which cuts the genome in a specific place. After cutting the DNA in a specific place, the cell naturally repairs itself. It finds application in large number of areas, such as mutation, therapeutics, and agriculture biotechnology. Rise in the number of chronic and infectious diseases is likely to expand the scope of genome editing in the coming years.

The Global Genome Editing Market is segmented based on technique, application, delivery method, end-user, region and company. Based on technique, the market is segmented into CRISPR, TALENs, Zinc Finger Nucleases and others. CRISPR dominates the market in this segment and is expected to be the fastest growing segment because as it is cheaper and is the most efficient technique among the rest. Based on application, the market is segmented into cell line engineering, animal genetic engineering, plant genetic engineering and others. Among them, the cell line engineering is expected to witness the highest growth rate in the coming years due to increase in the number of people suffering with genetic disorders and rising government funding for stem cell research.

Based on end-user, the Global Genome Editing Market is segmented into pharmaceutical & biotechnology companies, clinical research organization and research institutes. Pharmaceutical & biotechnology companies contribute to the largest share of revenue generation for the Global Genome Editing Market. Growing establishment of biotech and pharma companies in emerging economies and growing usage of gene editing technique in research activities undertaken by them to manufacture and develop drugs for rare diseases are the enablers for the growth of the market.

The major players operating in the Global Genome Editing Market are Thermo Fisher Scientific Inc., Homology Medicines, Inc., CRISPR Therapeutics AG, Pfizer Inc., Editas Medicine Inc., Intellia Therapeutics Inc., Cellectis SA, Sangamo Therapeutics Inc., Origene Technologies Inc., Merck & Co Inc., New England Biolabs Inc., Lonza Group AG, Danaher Corporation (Integrated DNA Technologies Inc.), PerkinElmer Inc. (Horizon Discovery Group Plc), Genscript Corp., Oxford Genetics Ltd., Bayer AG, Arcturus Therapeutics Inc, Inscripta Inc., Beam therapeutics Inc. and others. Growing number of research and development is going to drive the genome editing market in the coming years.

Years considered for this report:

  • Historical Years: 2016-2019
  • Base Year: 2020
  • Estimated Year: 2021
  • Forecast Period: 2022- 2026

Objective of the Study:

  • To analyze the historical growth in the market size of the Global Genome Editing Market from 2016 to 2020.
  • To estimate and forecast the market size of the Global Genome Editing Market from 2021 to 2026 and growth rate until 2026.
  • To classify and forecast the Global Genome Editing Market based on technique, application, delivery method, end-user, company and region.
  • To identify drivers and challenges for the Global Genome Editing Market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Global Genome Editing Market.
  • To conduct pricing analysis for the Global Genome Editing Market.
  • To identify and analyze the profile of leading players operating in the Global Genome Editing Market.

The publisher performed both primary as well as exhaustive secondary research for this study. Initially, the publisher sourced a list of companies across the globe. Subsequently, the publisher conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, the publisher could include the companies which could not be identified due to the limitations of secondary research. The publisher analyzed the presence of all major players across the globe.

The publisher calculated the market size of the Global Genome Editing Market by using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. The publisher sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.

Key Target Audience:

  • Genome editing companies
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to genome editing

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as companies, partners, end-users, etc., besides allowing them in strategizing investments and capitalizing on the market opportunities.

Report Scope:

In this report, the Global Genome Editing Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Global Genome Editing Market, By Technique:

  • CRISPR
  • TALENs
  • Zinc Finger Nucleases
  • Others

Global Genome Editing Market, By Application:

  • Cell Line Engineering
  • Animal Genetic Engineering
  • Plant Genetic Engineering
  • Others

Global Genome Editing Market, By Delivery Method:

  • Ex-vivo
  • In-vivo

Global Genome Editing Market, By End-User:

  • Pharmaceutical & Biotechnology Companies
  • Clinical Research Organization
  • Research Institutes

Global Genome Editing Market, By Region:

  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East and Africa

Competitive Landscape:

Company Profiles: Detailed analysis of the major companies present in the Global Genome Editing Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company’s specific needs.

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Arcturus Therapeutics Inc
  • Beam therapeutics Inc.
  • CRISPR Therapeutics AG
  • Genscript Corp.
  • Inscripta Inc.
  • Merck & Co Inc.
1. Product Overview

2. Research Methodology

3. Voice of Customer
3.1. Factors Driving the Global Genome Editing Market
3.2. Technology Compatibility
3.3. Unmet Needs and Challenges

4. Impact of COVID-19 on Global Genome Editing Market

5. Executive Summary

6. Global Genome Editing Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Technique (CRISPR, TALENs, Zinc Finger Nucleases, Others)
6.2.2. By Application (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, Others)
6.2.3. By Delivery Method (Ex-vivo, In-vivo)
6.2.4. By End User (Pharmaceutical & Biotechnology Companies, Clinical Research Organization, Research Institutes)
6.2.5. By Company (2020)
6.2.6. By Region
6.3. Product Market Map

7. North America Genome Editing Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Technique
7.2.2. By Application
7.2.3. By Delivery Method
7.2.4. By End User
7.2.5. By Country
7.3. North America: Country Analysis
7.3.1. United States Genome Editing Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Technique
7.3.1.2.2. By Application
7.3.1.2.3. By Delivery Method
7.3.1.2.4. By End User
7.3.2. Canada Genome Editing Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Technique
7.3.2.2.2. By Application
7.3.2.2.3. By Delivery Method
7.3.2.2.4. By End User
7.3.3. Mexico Genome Editing Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Technique
7.3.3.2.2. By Application
7.3.3.2.3. By Delivery Method
7.3.3.2.4. By End User

8. Europe Genome Editing Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Technique
8.2.2. By Application
8.2.3. By Delivery Method
8.2.4. By End User
8.2.5. By Country
8.3. Europe: Country Analysis
8.3.1. Germany Genome Editing Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Technique
8.3.1.2.2. By Application
8.3.1.2.3. By Delivery Method
8.3.1.2.4. By End User
8.3.2. United Kingdom Genome Editing Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Technique
8.3.2.2.2. By Application
8.3.2.2.3. By Delivery Method
8.3.2.2.4. By End User
8.3.3. France Genome Editing Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Technique
8.3.3.2.2. By Application
8.3.3.2.3. By Delivery Method
8.3.3.2.4. By End User
8.3.4. Italy Genome Editing Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Technique
8.3.4.2.2. By Application
8.3.4.2.3. By Delivery Method
8.3.4.2.4. By End User
8.3.5. Spain Genome Editing Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Technique
8.3.5.2.2. By Application
8.3.5.2.3. By Delivery Method
8.3.5.2.4. By End User

9. Asia-Pacific Genome Editing Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Technique
9.2.2. By Application
9.2.3. By Delivery Method
9.2.4. By End User
9.2.5. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Genome Editing Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Technique
9.3.1.2.2. By Application
9.3.1.2.3. By Delivery Method
9.3.1.2.4. By End User
9.3.2. Japan Genome Editing Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Technique
9.3.2.2.2. By Application
9.3.2.2.3. By Delivery Method
9.3.2.2.4. By End User
9.3.3. India Genome Editing Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Technique
9.3.3.2.2. By Application
9.3.3.2.3. By Delivery Method
9.3.3.2.4. By End User
9.3.4. South Korea Genome Editing Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Technique
9.3.4.2.2. By Application
9.3.4.2.3. By Delivery Method
9.3.4.2.4. By End User
9.3.5. Australia Genome Editing Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Technique
9.3.5.2.2. By Application
9.3.5.2.3. By Delivery Method
9.3.5.2.4. By End User

10. South America Genome Editing Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Technique
10.2.2. By Application
10.2.3. By Delivery Method
10.2.4. By End User
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Genome Editing Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Technique
10.3.1.2.2. By Application
10.3.1.2.3. By Delivery Method
10.3.1.2.4. By End User
10.3.2. Argentina Genome Editing Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Technique
10.3.2.2.2. By Application
10.3.2.2.3. By Delivery Method
10.3.2.2.4. By End User
10.3.3. Colombia Genome Editing Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Technique
10.3.3.2.2. By Application
10.3.3.2.3. By Delivery Method
10.3.3.2.4. By End User

11. Middle East and Africa Genome Editing Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Technique
11.2.2. By Application
11.2.3. By Delivery Method
11.2.4. By End User
11.2.5. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Genome Editing Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Technique
11.3.1.2.2. By Application
11.3.1.2.3. By Delivery Method
11.3.1.2.4. By End User
11.3.2. Saudi Arabia Genome Editing Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Technique
11.3.2.2.2. By Application
11.3.2.2.3. By Delivery Method
11.3.2.2.4. By End User
11.3.3. UAE Genome Editing Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Technique
11.3.3.2.2. By Application
11.3.3.2.3. By Delivery Method
11.3.3.2.4. By End User

12. Market Dynamics
12.1. Drivers
12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape
14.1. Competition Outlook
14.2. Players Profiled (Leading Companies)
14.2.1. Thermo Fisher Scientific Inc.
14.2.2. Homology Medicines, Inc.
14.2.3. CRISPR Therapeutics AG
14.2.4. Pfizer Inc.
14.2.5. Editas Medicine Inc.
14.2.6. Intellia Therapeutics Inc.
14.2.7. Cellectis SA
14.2.8. Sangamo Therapeutics Inc.
14.2.9. Origene Technologies Inc.
14.2.10. Merck & Co Inc.
14.2.11. New England Biolabs Inc.
14.2.12. Lonza Group AG
14.2.13. Danaher Corporation (Integrated DNA Technologies Inc.)
14.2.14. PerkinElmer Inc. (Horizon Discovery Group Plc)
14.2.15. Genscript Corp.
14.2.16. Oxford Genetics Ltd.
14.2.17. Bayer AG
14.2.18. Arcturus Therapeutics Inc
14.2.19. Inscripta Inc.
14.2.20. Beam therapeutics Inc.

15. Strategic Recommendations

16. About the Publisher & Disclaimer

List of Figures
Figure 1: Global Genome Editing Market Size, By Value (USD Million), 2016-2026F
Figure 2: Global Genome Editing Market Share, By Technique, By Value, 2016-2026F
Figure 3: Global Genome Editing Market Share, By Application, By Value, 2016-2026F
Figure 4: Global Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
Figure 5: Global Genome Editing Market Share, By End User, By Value, 2016-2026F
Figure 6: Global Genome Editing Market Share, By Company, By Value, 2020
Figure 7: Global Genome Editing Market Share, By Region, By Value, 2016-2026F
Figure 8: Global Genome Editing Product Market Map, By Value, 2016-2026F
Figure 9: North America Genome Editing Market Size, By Value (USD Million), 2016-2026F
Figure 10: North America Genome Editing Market Share, By Technique, By Value, 2016-2026F
Figure 11: North America Genome Editing Market Share, By Application, By Value, 2016-2026F
Figure 12: North America Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
Figure 13: North America Genome Editing Market Share, By End User, By Value, 2016-2026F
Figure 14: North America Genome Editing Market Share, By Country, By Value, 2016-2026F
Figure 15: United States Genome Editing Market Size, By Value (USD Million), 2016-2026F
Figure 16: United States Genome Editing Market Share, By Technique, By Value, 2016-2026F
Figure 17: United States Genome Editing Market Share, By Application, By Value, 2016-2026F
Figure 18: United States Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
Figure 19: United States Genome Editing Market Share, By End User, By Value, 2016-2026F
Figure 20: Canada Genome Editing Market Size, By Value (USD Million), 2016-2026F
Figure 21: Canada Genome Editing Market Share, By Technique, By Value, 2016-2026F
Figure 22: Canada Genome Editing Market Share, By Application, By Value, 2016-2026F
Figure 23: Canada Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
Figure 24: Canada Genome Editing Market Share, By End User, By Value, 2016-2026F
Figure 25: Mexico Genome Editing Market Size, By Value (USD Million), 2016-2026F
Figure 26: Mexico Genome Editing Market Share, By Technique, By Value, 2016-2026F
Figure 27: Mexico Genome Editing Market Share, By Application, By Value, 2016-2026F
Figure 28: Mexico Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
Figure 29: Mexico Genome Editing Market Share, By End User, By Value, 2016-2026F
Figure 30: Europe Genome Editing Market Size, By Value (USD Million), 2016-2026F
Figure 31: Europe Genome Editing Market Share, By Technique, By Value, 2016-2026F
Figure 32: Europe Genome Editing Market Share, By Application, By Value, 2016-2026F
Figure 33: Europe Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
Figure 34: Europe Genome Editing Market Share, By End User, By Value, 2016-2026F
Figure 35: Europe Genome Editing Market Share, By Country, By Value, 2016-2026F
Figure 36: Germany Genome Editing Market Size, By Value (USD Million), 2016-2026F
Figure 37: Germany Genome Editing Market Share, By Technique, By Value, 2016-2026F
Figure 38: Germany Genome Editing Market Share, By Application, By Value, 2016-2026F
Figure 39: Germany Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
Figure 40: Germany Genome Editing Market Share, By End User, By Value, 2016-2026F
Figure 41: United Kingdom Genome Editing Market Size, By Value (USD Million), 2016-2026F
Figure 42: United Kingdom Genome Editing Market Share, By Technique, By Value, 2016-2026F
Figure 43: United Kingdom Genome Editing Market Share, By Application, By Value, 2016-2026F
Figure 44: United Kingdom Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
Figure 45: United Kingdom Genome Editing Market Share, By End User, By Value, 2016-2026F
Figure 46: France Genome Editing Market Size, By Value (USD Million), 2016-2026F
Figure 47: France Genome Editing Market Share, By Technique, By Value, 2016-2026F
Figure 48: France Genome Editing Market Share, By Application, By Value, 2016-2026F
Figure 49: France Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
Figure 50: France Genome Editing Market Share, By End User, By Value, 2016-2026F
Figure 51: Italy Genome Editing Market Size, By Value (USD Million), 2016-2026F
Figure 52: Italy Genome Editing Market Share, By Technique, By Value, 2016-2026F
Figure 53: Italy Genome Editing Market Share, By Application, By Value, 2016-2026F
Figure 54: Italy Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
Figure 55: Italy Genome Editing Market Share, By End User, By Value, 2016-2026F
Figure 56: Spain Genome Editing Market Size, By Value (USD Million), 2016-2026F
Figure 57: Spain Genome Editing Market Share, By Technique, By Value, 2016-2026F
Figure 58: Spain Genome Editing Market Share, By Application, By Value, 2016-2026F
Figure 59: Spain Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
Figure 60: Spain Genome Editing Market Share, By End User, By Value, 2016-2026F
Figure 61: Asia-Pacific Genome Editing Market Size, By Value (USD Million), 2016-2026F
Figure 62: Asia-Pacific Genome Editing Market Share, By Technique, By Value, 2016-2026F
Figure 63: Asia-Pacific Genome Editing Market Share, By Application, By Value, 2016-2026F
Figure 64: Asia-Pacific Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
Figure 65: Asia-Pacific Genome Editing Market Share, By End User, By Value, 2016-2026F
Figure 66: Asia-Pacific Genome Editing Market Share, By Country, By Value, 2016-2026F
Figure 67: China Genome Editing Market Size, By Value (USD Million), 2016-2026F
Figure 68: China Genome Editing Market Share, By Technique, By Value, 2016-2026F
Figure 69: China Genome Editing Market Share, By Application, By Value, 2016-2026F
Figure 70: China Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
Figure 71: China Genome Editing Market Share, By End User, By Value, 2016-2026F
Figure 72: Japan Genome Editing Market Size, By Value (USD Million), 2016-2026F
Figure 73: Japan Genome Editing Market Share, By Technique, By Value, 2016-2026F
Figure 74: Japan Genome Editing Market Share, By Application, By Value, 2016-2026F
Figure 75: Japan Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
Figure 76: Japan Genome Editing Market Share, By End User, By Value, 2016-2026F
Figure 77: India Genome Editing Market Size, By Value (USD Million), 2016-2026F
Figure 78: India Genome Editing Market Share, By Technique, By Value, 2016-2026F
Figure 79: India Genome Editing Market Share, By Application, By Value, 2016-2026F
Figure 80: India Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
Figure 81: India Genome Editing Market Share, By End User, By Value, 2016-2026F
Figure 82: South Korea Genome Editing Market Size, By Value (USD Million), 2016-2026F
Figure 83: South Korea Genome Editing Market Share, By Technique, By Value, 2016-2026F
Figure 84: South Korea Genome Editing Market Share, By Application, By Value, 2016-2026F
Figure 85: South Korea Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
Figure 86: South Korea Genome Editing Market Share, By End User, By Value, 2016-2026F
Figure 87: Australia Genome Editing Market Size, By Value (USD Million), 2016-2026F
Figure 88: Australia Genome Editing Market Share, By Technique, By Value, 2016-2026F
Figure 89: Australia Genome Editing Market Share, By Application, By Value, 2016-2026F
Figure 90: Australia Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
Figure 91: Australia Genome Editing Market Share, By End User, By Value, 2016-2026F
Figure 92: South America Genome Editing Market Size, By Value (USD Million), 2016-2026F
Figure 93: South America Genome Editing Market Share, By Technique, By Value, 2016-2026F
Figure 94: South America Genome Editing Market Share, By Application, By Value, 2016-2026F
Figure 95: South America Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
Figure 96: South America Genome Editing Market Share, By End User, By Value, 2016-2026F
Figure 97: South America Genome Editing Market Share, By Country, By Value, 2016-2026F
Figure 98: Brazil Genome Editing Market Size, By Value (USD Million), 2016-2026F
Figure 99: Brazil Genome Editing Market Share, By Technique, By Value, 2016-2026F
Figure 100: Brazil Genome Editing Market Share, By Application, By Value, 2016-2026F
Figure 101: Brazil Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
Figure 102: Brazil Genome Editing Market Share, By End User, By Value, 2016-2026F
Figure 103: Argentina Genome Editing Market Size, By Value (USD Million), 2016-2026F
Figure 104: Argentina Genome Editing Market Share, By Technique, By Value, 2016-2026F
Figure 105: Argentina Genome Editing Market Share, By Application, By Value, 2016-2026F
Figure 106: Argentina Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
Figure 107: Argentina Genome Editing Market Share, By End User, By Value, 2016-2026F
Figure 108: Colombia Genome Editing Market Size, By Value (USD Million), 2016-2026F
Figure 109: Colombia Genome Editing Market Share, By Technique, By Value, 2016-2026F
Figure 110: Colombia Genome Editing Market Share, By Application, By Value, 2016-2026F
Figure 111: Colombia Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
Figure 112: Colombia Genome Editing Market Share, By End User, By Value, 2016-2026F
Figure 113: Middle East and Africa Genome Editing Market Size, By Value (USD Million), 2016-2026F
Figure 114: Middle East and Africa Genome Editing Market Share, By Technique, By Value, 2016-2026F
Figure 115: Middle East and Africa Genome Editing Market Share, By Application, By Value, 2016-2026F
Figure 116: Middle East and Africa Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
Figure 117: Middle East and Africa Genome Editing Market Share, By End User, By Value, 2016-2026F
Figure 118: Middle East and Africa Genome Editing Market Share, By Country, By Value, 2016-2026F
Figure 119: South Africa Genome Editing Market Size, By Value (USD Million), 2016-2026F
Figure 120: South Africa Genome Editing Market Share, By Technique, By Value, 2016-2026F
Figure 121: South Africa Genome Editing Market Share, By Application, By Value, 2016-2026F
Figure 122: South Africa Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
Figure 123: South Africa Genome Editing Market Share, By End User, By Value, 2016-2026F
Figure 124: Saudi Arabia Genome Editing Market Size, By Value (USD Million), 2016-2026F
Figure 125: Saudi Arabia Genome Editing Market Share, By Technique, By Value, 2016-2026F
Figure 126: Saudi Arabia Genome Editing Market Share, By Application, By Value, 2016-2026F
Figure 127: Saudi Arabia Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
Figure 128: Saudi Arabia Genome Editing Market Share, By End User, By Value, 2016-2026F
Figure 129: UAE Genome Editing Market Size, By Value (USD Million), 2016-2026F
Figure 130: UAE Genome Editing Market Share, By Technique, By Value, 2016-2026F
Figure 131: UAE Genome Editing Market Share, By Application, By Value, 2016-2026F
Figure 132: UAE Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
Figure 133: UAE Genome Editing Market Share, By End User, By Value, 2016-2026F
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Thermo Fisher Scientific Inc.
  • Homology Medicines, Inc.
  • CRISPR Therapeutics AG
  • Pfizer Inc.
  • Editas Medicine Inc.
  • Intellia Therapeutics Inc.
  • Cellectis SA
  • Sangamo Therapeutics Inc.
  • Origene Technologies Inc.
  • Merck & Co Inc.
  • New England Biolabs Inc.
  • Lonza Group AG
  • Danaher Corporation (Integrated DNA Technologies Inc.)
  • PerkinElmer Inc. (Horizon Discovery Group Plc)
  • Genscript Corp.
  • Oxford Genetics Ltd.
  • Bayer AG
  • Arcturus Therapeutics Inc
  • Inscripta Inc.
  • Beam therapeutics Inc.
Note: Product cover images may vary from those shown
Adroll
adroll